Table 3.
Cumulative Incidence of Recurrent VTE During First Anticoagulant by Type of Initial Anticoagulation.
Anticoagulant Regimen | Patients on Regimen | Recurrent VTE, # (%) | 3-Month VTE Recurrence, (%) | 6-Month VTE Recurrence, (%) | Incidence rate (per 1000 person-months) |
---|---|---|---|---|---|
Warfarin | 132 | 7 (5.3%) | 4.0% | 4.0% | 4.0 |
Enoxaparin | 53 | 9 (17.0%) | 6.6% | 10.3% | 24.4 |
Dalteparin | 37 | 1 (2.7%) | 3.0% | 3.0% | 2.6 |
Fondaparinux | 14 | 1 (7.1%) | 0.0% | 7.7% | 5.0 |
Gray test | 0.004 |
Abbreviation: VTE, venous thromboembolism.